| Patent | Date |
|---|
LHRH--antagonists in the treatment of fertility disorders
Grant 9,107,871 - Bouchard , et al. August 18, 2 | 2015-08-18 |
Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
Grant 8,921,318 - Engel , et al. December 30, 2 | 2014-12-30 |
Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
Grant 8,551,977 - Engel , et al. October 8, 2 | 2013-10-08 |
Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
Grant 8,507,710 - Engel , et al. August 13, 2 | 2013-08-13 |
Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals
Grant 8,389,497 - Engel , et al. March 5, 2 | 2013-03-05 |
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
Grant 8,383,605 - Engel , et al. February 26, 2 | 2013-02-26 |
Method for a programmed controlled ovarian stimulation protocol
Grant 8,173,592 - Engel , et al. May 8, 2 | 2012-05-08 |
Lhrh - Antagonists In The Treatment Of Fertility Disorders
App 20110306547 - BOUCHARD; PHILIPPE ; et al. | 2011-12-15 |
Process for preventing protozoal diseases
Grant 7,887,817 - Engel February 15, 2 | 2011-02-15 |
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
App 20110028421 - Engel; Jurgen ; et al. | 2011-02-03 |
Injection solution of an LHRH antagonist
Grant 7,790,686 - Sarlikiotis , et al. September 7, 2 | 2010-09-07 |
Use of Aalkylphophocholines in Combination with Antitumor Medication for the Treatment of Benign and Melignant Oncoses in Humans and Mammals
App 20100190738 - Engel; Jurgen ; et al. | 2010-07-29 |
Use of Alkylphophocholine in Combination with Antitumor Medication for the Treatment of Benign and Malignant Oncoses in Humans and Mammals
App 20100189784 - Engel; Jurgen ; et al. | 2010-07-29 |
Moulded Skin and Method for Production Thereof
App 20100104828 - Engel; Jurgen ; et al. | 2010-04-29 |
Method for the therapeutic management of endometriosis
Grant 7,666,836 - Riethmuller-Winzen , et al. February 23, 2 | 2010-02-23 |
Oligopeptide lyophilisate, their preparation and use
Grant 7,605,121 - Engel , et al. October 20, 2 | 2009-10-20 |
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
Grant 7,452,910 - Nickel , et al. November 18, 2 | 2008-11-18 |
Method For The Therapeutic Management Of Endometriosis
App 20080255053 - RIETHMULLER-WINZEN; Hilde ; et al. | 2008-10-16 |
LHRH-antagonists in the treatment of fertility disorders
Grant 7,393,834 - Bouchard , et al. July 1, 2 | 2008-07-01 |
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
App 20080057124 - Nickel; Bernd ; et al. | 2008-03-06 |
Application Of Initial Doses Of Lhrh Analogues And Maintenance Doses Of Lhrh Antagonists For The Treatment Of Hormone-dependent Cancers And Corresponding Pharmaceutical Kits
App 20080032935 - ENGEL; Jurgen ; et al. | 2008-02-07 |
Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
Grant 7,288,517 - Engel , et al. October 30, 2 | 2007-10-30 |
Injection solution of an LHRH antagonist
App 20070161571 - Sarlikiotis; Werner ; et al. | 2007-07-12 |
Injectable solution of an LHRH antagonist
Grant 7,214,662 - Sarlikiotis , et al. May 8, 2 | 2007-05-08 |
Method for the therapeutic management of endometriosis
App 20060100155 - Riethmuller-Winzen; Hilde ; et al. | 2006-05-11 |
Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
Grant 7,005,418 - Riethmuller-Winzen , et al. February 28, 2 | 2006-02-28 |
Oligopeptide lyophilisate, their preparation and use
App 20050124546 - Engel, Jurgen ; et al. | 2005-06-09 |
Disease treatment with novel phospholipid derivatives
Grant 6,903,080 - Nossner , et al. June 7, 2 | 2005-06-07 |
Preparation and use of oligopeptide lyophilisate for gonad protection
Grant 6,867,191 - Engel , et al. March 15, 2 | 2005-03-15 |
Oligopeptide lyophilisate, their preparation and use
Grant 6,863,891 - Engel , et al. March 8, 2 | 2005-03-08 |
LHRH-antagonists in the treatment of fertility disorders
App 20050049200 - Bouchard, Philippe ; et al. | 2005-03-03 |
Method for the synthesis of peptide salts, their use and pharmaceutical preparations containing the peptide salts
App 20040259801 - Damm, Michael ; et al. | 2004-12-23 |
Oligopeptide lyophilisate, their preparation and use
Grant 6,828,415 - Engel , et al. December 7, 2 | 2004-12-07 |
Pharmaceutical formulation for preventing protozoal diseases
App 20040242543 - Engel, Jurgen | 2004-12-02 |
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
App 20040171668 - Nickel, Bernd ; et al. | 2004-09-02 |
Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
Grant 6,780,972 - Damm , et al. August 24, 2 | 2004-08-24 |
Use of LHRH-antagonists in doses that do not cause castration for the improvement of T-cell mediated immunity
App 20040138138 - Engel, Jurgen ; et al. | 2004-07-15 |
Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals
App 20040097470 - Engel, Jurgen ; et al. | 2004-05-20 |
Method of treatment of female infertility
Grant 6,716,817 - Engel , et al. April 6, 2 | 2004-04-06 |
Use of dopamine receptor antagonists in palliative tumor therapy
Grant 6,696,428 - Nickel , et al. February 24, 2 | 2004-02-24 |
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
Grant 6,693,119 - Nickel , et al. February 17, 2 | 2004-02-17 |
Oral forms of administration containing solid flupirtine with controlled release of active substance
Grant 6,667,058 - Goede , et al. December 23, 2 | 2003-12-23 |
Process for preventing protozoal diseases
App 20030216355 - Engel, Jurgen | 2003-11-20 |
Novel phospholipid derivatives
App 20030153533 - Nossner, Gerhard ; et al. | 2003-08-14 |
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
App 20030114511 - Nickel, Bernd ; et al. | 2003-06-19 |
Injectable solution of an LHRH antagonist
App 20030100509 - Sarlikiotis, Werner ; et al. | 2003-05-29 |
Pharmaceutical composition comprising ifosfamide and carnitine
App 20030040507 - Nickel, Bernd ; et al. | 2003-02-27 |
Use of dopamine receptor antagonists in palliative tumor therapy
App 20030008846 - Nickel, Bernd ; et al. | 2003-01-09 |
Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
App 20020198146 - Damm, Michael ; et al. | 2002-12-26 |
Oligopeptide lyophilisate, their preparation and use
App 20020198186 - Engel, Jurgen ; et al. | 2002-12-26 |
Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
App 20020177556 - Engel, Jurgen ; et al. | 2002-11-28 |
Antihistamine leukotriene combinations
Grant 6,436,924 - Poppe , et al. August 20, 2 | 2002-08-20 |
Oligopeptide lyophilisate, their preparation and use
App 20020103113 - Engel, Jurgen ; et al. | 2002-08-01 |
Oligopeptide Lyophilisate, Their Preparation And Use
App 20020099018 - ENGEL, JURGEN ; et al. | 2002-07-25 |
Cyclophosphamide Film-coated Tablets
App 20010046504 - ENGEL, JURGEN ; et al. | 2001-11-29 |
Means for treating prostate hypertrophy and prostate cancer
Grant 6,300,313 - Engel , et al. October 9, 2 | 2001-10-09 |
Antihistamine leukotriene combinations
App 20010025040 - Poppe, Hildegard ; et al. | 2001-09-27 |
Pharmaceutical compositions containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient
Grant 6,271,254 - Ulrich , et al. August 7, 2 | 2001-08-07 |
Methods of treating protozoal diseases
App 20010008885 - Eibl, Hansjorg ; et al. | 2001-07-19 |
Means for treating prostate hypertrophy and prostate cancer
Grant 6,054,432 - Engel , et al. April 25, 2 | 2000-04-25 |
Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation
Grant 6,022,860 - Engel , et al. February 8, 2 | 2000-02-08 |
Magnet armature
Grant 6,019,344 - Engel , et al. February 1, 2 | 2000-02-01 |
Nova- and decapeptides in the preparation of a drug for the treatment of aids
Grant 5,985,834 - Engel , et al. November 16, 1 | 1999-11-16 |
Long-acting injection suspensions and a process for their preparation
Grant 5,773,032 - Engel , et al. June 30, 1 | 1998-06-30 |
Pharmaceutical composition containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient
Grant 5,728,735 - Ulrich , et al. March 17, 1 | 1998-03-17 |
Injectable mesna solutions
Grant 5,728,738 - Engel , et al. March 17, 1 | 1998-03-17 |
Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
Grant 5,721,258 - Schwarz , et al. February 24, 1 | 1998-02-24 |
Phthalazinone derivatives that modulate multi-drug resistance
Grant 5,556,856 - Engel , et al. September 17, 1 | 1996-09-17 |
Combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
Grant 5,521,178 - Nickel , et al. May 28, 1 | 1996-05-28 |
Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms
Grant 5,503,845 - Goede , et al. April 2, 1 | 1996-04-02 |
Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
Grant 5,446,033 - Engel , et al. August 29, 1 | 1995-08-29 |
4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation
Grant 5,405,847 - Dieter , et al. April 11, 1 | 1995-04-11 |
Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them
Grant 5,384,330 - Dieter , et al. January 24, 1 | 1995-01-24 |
Tablet containing mesna as active substance and method of making same
Grant 5,358,718 - Sauerbier , et al. October 25, 1 | 1994-10-25 |
Tablets and granulates containing mesna as active substance
Grant 5,262,169 - Sauerbier , et al. November 16, 1 | 1993-11-16 |
Tablets and granulates containing mesna as active substance
Grant 5,252,341 - Sauerbier , et al. October 12, 1 | 1993-10-12 |
Azelastine embonate and compositions which contain it
Grant 5,232,919 - Scheffler , et al. August 3, 1 | 1993-08-03 |
Pharmaceutical composition comprising flupirtine and its use to combat muscular tension
Grant 5,162,346 - Lobisch , et al. November 10, 1 | 1992-11-10 |
Azelastine and its salts used to combat psoriasis
Grant 5,110,814 - Engel , et al. May 5, 1 | 1992-05-05 |
Nitrogen-containing cyclo-aliphatic compounds having an amino radical and a pyridine radical
Grant 4,946,836 - Engel , et al. August 7, 1 | 1990-08-07 |
Substituted 3-(n-heterocyclic)-2,6-diaminopyridines and -n-oxides
Grant 4,923,858 - Engel , et al. May 8, 1 | 1990-05-08 |
Process for the preparation of ifosfamide having improved properties
Grant 4,882,452 - Engel , et al. November 21, 1 | 1989-11-21 |
4-benzyl-1-(2H)-phthalazinone-derivates
Grant 4,841,047 - Engel , et al. June 20, 1 | 1989-06-20 |
Salts of oxazaphosphorine derivatives
Grant 4,716,242 - Engel , et al. December 29, 1 | 1987-12-29 |
Analgesic pyridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
Grant 4,643,995 - Engel , et al. February 17, 1 | 1987-02-17 |
2-Amino-3-acylamino-6-benzylamino-pyridine-derivative having antiepileptic action
Grant 4,554,281 - vonBebenburg, deceased , et al. November 19, 1 | 1985-11-19 |
| 